Kikuchi disease overview: Difference between revisions

Jump to navigation Jump to search
Shankar Kumar (talk | contribs)
No edit summary
WikiBot (talk | contribs)
m Changes made per Mahshid's request
 
(5 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Kikuchi's disease (histiocytic necrotizing lymphadenitis) is a rare, non-cancerous enlargement of the [[lymph node]]s: the diagnosis can be confirmed by lymph node biopsy. It was originally described in Japan by Dr M. Kikuchi in 1972.<ref>Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes. ''Acta Hematol Jpn'' 1972;35:379–80.<!--No PMID--></ref>
Kikuchi's disease (histiocytic necrotizing lymphadenitis) is a rare, non-[[cancerous]] enlargement of the [[lymph node]]s: the [[diagnosis]] can be confirmed by [[lymph node biopsy]].
 
==Historical Perspective==
Kikuchi-Fujimoto disease (KFD) was described in 1972 in Japan by Dr Masahiro Kikuchi in 1972<ref>Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes. ''Acta Hematol Jpn'' 1972;35:379–80.<!--No PMID--></ref> and independently by Y. Fujimoto.
==Causes==
The cause for Kikuchi disease has not been established although [[infectious]] and [[autoimmune disease|autoimmune]] [[etiology|etiologies]] have been proposed.
==Diagnosis==
===Laboratory Findings===
Kikuchi disease is [[diagnose]]d by [[lymph node]] [[excisional biopsy]]. [[antinuclear antibody|ANA]], [[antiphospholipid antibody|APLA]], [[anti-dsDNA]], [[rheumatoid factor|RF]] are usually negative, and may help in differentiating from [[SLE]]. [[Laboratory]] findings may sometimes include positive results for [[IgM]], [[IgG]] or [[IgA]] [[antibodies]].
==Treatment==
===Medical Therapy===
There is no specific cure for Kikuchi disease. Treatment is largely supportive. [[NSAID]]s are useful if [[patient]] presents with [[tenderness (medicine)|tender]] [[lymph node]]s and [[fever]]. [[Symptomatic]] measures aimed at relieving the distressing [[local]] and [[systemic]] [[chief complaint|complaints]] have been described as the main line of management of Kikuchi disease. [[Analgesic]]s, [[antipyretic]]s, [[nonsteroidal anti-inflammatory drug]]s ([[NSAID]]s) and corticosteroids have been used. [[Corticosteroid]]s are useful in severe extranodal or generalized disease. Multiple flares of bulky [[cervical]] [[lymphadenopathy]] and [[fever]] are treated with a low-dose corticosteroid.
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}
Line 10: Line 22:
{{WS}}
{{WS}}
[[Category:Rare diseases]]
[[Category:Rare diseases]]
[[Category:Infectious disease]]
[[Category:Needs overview]]

Latest revision as of 18:08, 18 September 2017

Kikuchi disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Kikuchi disease from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Kikuchi disease overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kikuchi disease overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kikuchi disease overview

CDC on Kikuchi disease overview

Kikuchi disease overview in the news

Blogs on Kikuchi disease overview

Directions to Hospitals Treating Kikuchi disease

Risk calculators and risk factors for Kikuchi disease overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Kikuchi's disease (histiocytic necrotizing lymphadenitis) is a rare, non-cancerous enlargement of the lymph nodes: the diagnosis can be confirmed by lymph node biopsy.

Historical Perspective

Kikuchi-Fujimoto disease (KFD) was described in 1972 in Japan by Dr Masahiro Kikuchi in 1972[1] and independently by Y. Fujimoto.

Causes

The cause for Kikuchi disease has not been established although infectious and autoimmune etiologies have been proposed.

Diagnosis

Laboratory Findings

Kikuchi disease is diagnosed by lymph node excisional biopsy. ANA, APLA, anti-dsDNA, RF are usually negative, and may help in differentiating from SLE. Laboratory findings may sometimes include positive results for IgM, IgG or IgA antibodies.

Treatment

Medical Therapy

There is no specific cure for Kikuchi disease. Treatment is largely supportive. NSAIDs are useful if patient presents with tender lymph nodes and fever. Symptomatic measures aimed at relieving the distressing local and systemic complaints have been described as the main line of management of Kikuchi disease. Analgesics, antipyretics, nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids have been used. Corticosteroids are useful in severe extranodal or generalized disease. Multiple flares of bulky cervical lymphadenopathy and fever are treated with a low-dose corticosteroid.

References

  1. Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes. Acta Hematol Jpn 1972;35:379–80.

Template:WH Template:WS